The role of thyroid-stimulating hormone and thyroglobulin antibody in abnormally invasive placenta

被引:3
|
作者
Ozler, Sibel [1 ]
Oztas, Efser [2 ]
Kebapcilar, Aysegul [3 ]
Caglar, Ali Turhan [4 ]
机构
[1] Selcuk Univ, Fac Med, Perinatol, TR-42050 Konya, Turkey
[2] Kutahya Univ Hlth Sci, Perinatol, Kutahya, Turkey
[3] Selcuk Univ, Fac Med, Obstet & Gynecol, Konya, Turkey
[4] TC Saglik Bakanligi Ankara Sehir Hastanesi, Perinatol, Ankara, Turkey
来源
关键词
Thyroid-stimulating antibody; thyroglobulin antibody; placenta accreta spectrum; cesarean hysterectomy; massive blood transfusion;
D O I
10.1080/14767058.2021.1875430
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose: Thyroid hormones and antibodies are known to participate in angiogenesis and invasion and also thyroid hormone receptors are expressed in the placenta. We aimed to evaluate the relationship of serum levels of thyroid-stimulating hormone (TSH), thyroid hormones (TH), and anti-thyroid antibodies with abnormally invasive placenta (AIP). We also aimed to investigate whether they are related with cesarean hysterectomy and massive blood transfusion need in AIP cases. Methods: A total of 88 pregnant patients were enrolled in this prospective case-control study (30 with AIP, 28 with non-adherent placenta previa totalis (PPT) and 30 controls). Serum TSH, thyroid hormone [T3 (triiodothyronine) and T4 (thyroxine)] and thyroid antibodies against thyroglobulin (TgAb) and thyroid peroxidase (TPOAb) levels were studied in maternal serum at initial admission to our Perinatology Unit (at early third trimester). The factors associated with increased risk of AIP, cesarean hysterectomy, massive blood transfusion, and adverse perinatal outcomes were evaluated with multiple logistic regression analysis. Adjusted odds ratios and 95% confidence intervals were also calculated. Results: Serum TSH and TgAb levels were significantly lower in the AIP group than both PPT and control groups (p = .01, p < .001 and p < .001, p < .001 respectively). Decreased serum levels of TSH (<2.16 mIU/L) and TgAb (<2.70 mIU/L) levels and high previous cesarean section rates were found to be independently associated with AIP in pregnant women with PPT (OR: 0.4, 95% CI: 0.1-0.9; p = .04, OR: 0.7, 95%CI: 0.4-1.3, p = .02 and OR: 0.1, 95% CI: 0.1-0.5, p = .01). Decreased serum TSH and TgAb levels were found to be independently associated with an increased rate of cesarean hysterectomy and massive blood transfusion in AIP cases (OR: 3.7, 95% CI: 1.4-9.8; p = .01, OR: 1.8, 95% CI: 1.1-3.1; p = .03 and OR: 2.6, 95% CI: 1.0-6.5; p = .05, OR: 2.2, 95% CI: 1.1-4.1 p = .02). Decreased TSH and TgAb serum levels were also found to be independently associated with adverse perinatal outcomes in AIP cases (OR: 3.4, 95% CI: 1.3-11.0; p = .01 and OR: 1.978, 95% CI: 2-3.6; p = .03). Conclusion: Decreased serum TSH and TgAb levels, and previous history of cesarean section were all found to be significantly associated with AIP in cases with PPT. We suggest that maternal serum TSH and TgAb levels can provide additional contribution to obstetric Doppler ultrasound in the diagnosis of AIP and thus can reduce the risks of unplanned cesarean hysterectomy in cases with PPT.
引用
收藏
页码:5108 / 5115
页数:8
相关论文
共 50 条
  • [1] Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody
    Ochi, Y
    Kajita, Y
    Hamazu, M
    Nagata, A
    [J]. HORMONE RESEARCH, 2003, 59 (05) : 222 - 228
  • [2] MELATONIN IN THE THYROID GLAND: REGULATION BY THYROID-STIMULATING HORMONE AND ROLE IN THYROGLOBULIN GENE EXPRESSION
    Garcia-Marin, R.
    Fernandez-Santos, J. M.
    Morillo-Bernal, J.
    Gordillo-Martinez, F.
    Vazquez-Roman, V.
    Utrilla, J. C.
    Carrillo-Vico, A.
    Guerrero, J. M.
    Martin-Lacave, I.
    [J]. JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2015, 66 (05): : 643 - 652
  • [3] The Role of Pre-ablative Stimulated Thyroglobulin and Thyroglobulin/Thyroid-Stimulating Hormone Ratio for Predicting Metastasis in Thyroid Cancer
    Demir, Fadime
    Simsek, Fikri Selcuk
    Balci, Tansel Ansal
    [J]. MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2019, 28 (01) : 21 - 26
  • [4] CHANGES IN STRUCTURE OF THYROGLOBULIN FOLLOWING ADMINISTRATION OF THYROID-STIMULATING HORMONE
    DUNN, JT
    RAY, SC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1975, 250 (15) : 5801 - 5807
  • [5] THYROID-STIMULATING HORMONE RECEPTOR AND THYROID-STIMULATING ANTIBODIES
    SMITH, BR
    HALL, R
    [J]. JOURNAL OF ENDOCRINOLOGY, 1974, 63 (02) : P59 - P60
  • [6] Predictive Value of Preablation Stimulated Thyroglobulin and Thyroglobulin/Thyroid-Stimulating Hormone Ratio in Differentiated Thyroid Cancer
    Lin, Yansong
    Li, Tianjun
    Liang, Jun
    Li, Xiaoyi
    Qiu, Liheng
    Wang, Shasha
    Chen, Yonghui
    Kang, Zengshou
    Li, Fang
    [J]. CLINICAL NUCLEAR MEDICINE, 2011, 36 (12) : 1102 - 1105
  • [7] The Thyroid-Stimulating Hormone Receptor: Impact of Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Antibodies on Multimerization, Cleavage, and Signaling
    Latif, Rauf
    Morshed, Syed A.
    Zaidi, Mone
    Davies, Terry F.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2009, 38 (02) : 319 - +
  • [8] THYROID-STIMULATING HORMONE
    PURVES, HD
    ADAMS, DD
    [J]. BRITISH MEDICAL BULLETIN, 1960, 16 (02) : 128 - 132
  • [9] Thyroid-Stimulating Antibody/Thyroid-Stimulating Hormone Receptor Antibody Ratio as a Sensitive Screening Test for Active Graves' Orbitopathy
    Nakano, Masayoshi
    Konishi, Hiroe
    Koshiba, Masahiro
    [J]. ENDOCRINE PRACTICE, 2022, 28 (10) : 1050 - 1054
  • [10] THYROID-STIMULATING HORMONE - ROLE OF DOPAMINE IN SECRETION
    HALL, R
    SCANLON, MF
    [J]. JOURNAL OF ENDOCRINOLOGY, 1979, 80 (02) : P18 - P19